119 related articles for article (PubMed ID: 16565673)
1. [Coma following chemotherapy: is 5FU implicated? Discussion about on case-report].
Heluwaert F; Santre C; Martin C; Hilleret MN; Martin D
Gastroenterol Clin Biol; 2006 Feb; 30(2):325-6. PubMed ID: 16565673
[TBL] [Abstract][Full Text] [Related]
2. [5-Fluorouracil-induced reticular hyperpigmentation].
Sanz-Sánchez T; Córdoba S; Jiménez-Ayala B; Borbujo JM
Actas Dermosifiliogr; 2008 Sep; 99(7):573-4. PubMed ID: 18682175
[No Abstract] [Full Text] [Related]
3. Successful management of hyperammonemia with hemodialysis on day 2 during 5-fluorouracil treatment in a patient with gastric cancer: a case report with 5-fluorouracil metabolite analyses.
Ozaki Y; Imamaki H; Ikeda A; Oura M; Nakagawa S; Funakoshi T; Kataoka S; Nishikawa Y; Horimatsu T; Yonezawa A; Matsubara T; Yanagita M; Muto M; Watanabe N
Cancer Chemother Pharmacol; 2020 Nov; 86(5):693-699. PubMed ID: 33011861
[TBL] [Abstract][Full Text] [Related]
4. [A case of 5-fluorouracil-induced hyperammmonia after chemotherapy for metastatic colon cancer].
Nakamura M; Kobashikawa K; Tamura J; Takaki R; Ohshiro M; Matayoshi R; Hirata T; Kinjyo F; Fujita J
Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1744-50. PubMed ID: 19966516
[TBL] [Abstract][Full Text] [Related]
5. Two cases of coronary vasospasm induced by 5-fluorouracil.
Atar A; Korkmaz ME; Ozin B
Anadolu Kardiyol Derg; 2010 Oct; 10(5):461-2. PubMed ID: 20929706
[No Abstract] [Full Text] [Related]
6. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
Y-Hassan S; Tornvall P; Törnerud M; Henareh L
Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine-induced cerebellar toxicity.
Renouf D; Gill S
Clin Colorectal Cancer; 2006 May; 6(1):70-1. PubMed ID: 16796795
[TBL] [Abstract][Full Text] [Related]
8. DPD functional tests in plasma, fresh saliva and dried saliva samples as predictors of 5-fluorouracil exposure and occurrence of drug-related severe toxicity.
Neto OV; Raymundo S; Franzoi MA; do Carmo Artmann A; Tegner M; Müller VV; Hahn RZ; Alves GV; Schwartsmann G; Linden R; Antunes MV
Clin Biochem; 2018 Jun; 56():18-25. PubMed ID: 29625079
[TBL] [Abstract][Full Text] [Related]
9. [Fatal acute encephalopathy due to 5-fluorouracil treatment].
Mémain N; Angellier JF; Obadia E; Angellier E; Chelha R; Couprie R
Presse Med; 2005 Dec; 34(21):1637-40. PubMed ID: 16327703
[TBL] [Abstract][Full Text] [Related]
10. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy.
Yeh KH; Cheng AL
Br J Cancer; 1997; 75(3):464-5. PubMed ID: 9020500
[No Abstract] [Full Text] [Related]
11. [pericarditis following 5-fluorouracil administration].
Maréchal S; Racaru V; Houbiers G; Graas MP
Rev Med Liege; 2015; 70(7-8):360-6. PubMed ID: 26376561
[TBL] [Abstract][Full Text] [Related]
12. Pneumatosis intestinalis due to 5-fluorouracil chemotherapy.
Vargas A; Pagés M; Buxó E
Gastroenterol Hepatol; 2016 Dec; 39(10):672-673. PubMed ID: 26547612
[No Abstract] [Full Text] [Related]
13. Severe hiccups during chemotherapy: corticosteroids the likely culprit.
Gilbar P; McPherson I
J Oncol Pharm Pract; 2009 Dec; 15(4):233-6. PubMed ID: 19276142
[TBL] [Abstract][Full Text] [Related]
14. Selective inflammatory effect of systemic fluorouracil in actinic keratosis.
Nabai H; Mohindra R; Mehregan D
Cutis; 1999 Jul; 64(1):43-4. PubMed ID: 10431671
[TBL] [Abstract][Full Text] [Related]
15. A patient with a prolonged prothrombin time due to an adverse interaction between 5-fluorouracil and warfarin.
Aki Z; Kotiloğlu G; Ozyilkan O
Am J Gastroenterol; 2000 Apr; 95(4):1093-4. PubMed ID: 10763974
[No Abstract] [Full Text] [Related]
16. Treatment of metastatic breast cancer with continuous infusional 5 fluorouracil.
Karapetis CS; Patterson WK; Pittman KB; Kotasek D; Sage RE
Aust N Z J Med; 1999 Aug; 29(4):517-22. PubMed ID: 10868530
[TBL] [Abstract][Full Text] [Related]
17. [A case of spinal infarction related to hepatic arterial infusion chemotherapy].
Shimizu J; Masutani S; Ishida H; Kishi K; Nakayama T; Imamura H; Tatsuta M; Furukawa H; Yura M; Saeki N; Kitamura S; Tomotsu K; Takamura M; Inoue Y
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1758-61. PubMed ID: 14619512
[TBL] [Abstract][Full Text] [Related]
18. Phase II evaluation of low-dose continuous 5-fluorouracil and weekly cisplatin in advanced adenocarcinoma of the stomach. A Southwest Oncology Group study.
Williamson SK; Tangen CM; Maddox AM; Spiridonidis CH; Macdonald JS
Am J Clin Oncol; 1995 Dec; 18(6):484-7. PubMed ID: 8526189
[TBL] [Abstract][Full Text] [Related]
19. [Reversible cardiogenic shock under 5-fluorouracil treatment].
Bakouboula B; Morel O; Douchet MP; Chauvin M
Ann Cardiol Angeiol (Paris); 2005 Aug; 54(4):216-9. PubMed ID: 16104623
[TBL] [Abstract][Full Text] [Related]
20. 5-Fluorouracil induced hyperammonemic encephalophathy: etiopathologic correlation.
Martinez-Lapiscina EH; Erro ME; Cabada T; Tuñón T
Can J Neurol Sci; 2012 Jul; 39(4):553-4. PubMed ID: 22896877
[No Abstract] [Full Text] [Related]
[Next] [New Search]
